140 related articles for article (PubMed ID: 9087491)
41. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
Leite EA; Grabe-Guimarães A; Guimarães HN; Machado-Coelho GL; Barratt G; Mosqueira VC
Life Sci; 2007 Mar; 80(14):1327-34. PubMed ID: 17303179
[TBL] [Abstract][Full Text] [Related]
42. A liquid chromatographic assay for the stereospecific quantitative analysis of halofantrine in human plasma.
Brocks DR; Dennis MJ; Schaefer WH
J Pharm Biomed Anal; 1995 Jun; 13(7):911-8. PubMed ID: 8562616
[TBL] [Abstract][Full Text] [Related]
43. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
[TBL] [Abstract][Full Text] [Related]
44. Redetermination of the crystal and molecular structure of the antimalarial chloroquine bis(dihydrogenphosphate) dihydrate.
Karle JM; Karle IL
Acta Crystallogr C; 1988 Sep; 44 ( Pt 9)():1605-8. PubMed ID: 3271099
[TBL] [Abstract][Full Text] [Related]
45. Iron(III) protoporphyrin IX complexes of the antimalarial Cinchona alkaloids quinine and quinidine.
de Villiers KA; Gildenhuys J; le Roex T
ACS Chem Biol; 2012 Apr; 7(4):666-71. PubMed ID: 22276975
[TBL] [Abstract][Full Text] [Related]
46. The crystal structure of 1,2,3,4,6-penta-O-benzoyl-alpha-D-mannopyranose: observation of C-H...pi interaction as a surrogate to O-H...O interaction of a free sugar.
Muktha B; Srinivas O; Amresh MR; Guru Row TN; Jayaraman N; Sekar K
Carbohydr Res; 2003 Sep; 338(19):2005-11. PubMed ID: 14499577
[TBL] [Abstract][Full Text] [Related]
47. Effect of fluconazole on the pharmacokinetics of halofantrine in healthy volunteers.
Babalola CP; Kolade YT; Olaniyi AA; Adedapo A; Scriba GK
J Clin Pharm Ther; 2009 Dec; 34(6):677-82. PubMed ID: 20175801
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of halofantrine in the rat: stereoselectivity and interspecies comparisons.
Brocks DR; Toni JW
Biopharm Drug Dispos; 1999 Apr; 20(3):165-9. PubMed ID: 10211870
[TBL] [Abstract][Full Text] [Related]
49. Quinidine as a muscarinic antagonist: a structural approach.
Ciechanowicz-Rutkowska M; Oleksyn BJ; Suszko-Purzycka A; Lipińska T
J Pharm Sci; 1992 Jun; 81(6):559-64. PubMed ID: 1522494
[TBL] [Abstract][Full Text] [Related]
50. Confirmation of the structure of (3S)-3-hydroxyquinine: synthesis and X-ray crystal structure of its 9-aceto analogue.
Srirama Sarma PV; Han D; Deschamps JR; Cook JM
J Nat Prod; 2005 Jun; 68(6):942-4. PubMed ID: 15974625
[TBL] [Abstract][Full Text] [Related]
51. Conformation of epicinchonine and cinchonine in view of their antimalarial activity: x-ray and theoretical studies.
Kowalik JT; Lipińska T; Oleksyn BJ; Sliwiński J
Enantiomer; 1999; 4(5):389-410. PubMed ID: 10644163
[TBL] [Abstract][Full Text] [Related]
52. Tetranuclear and Octanuclear Manganese Carboxylate Clusters: Preparation and Reactivity of (NBu(n)(4))[Mn(4)O(2)(O(2)CPh)(9)(H(2)O)] and Synthesis of (NBu(n)(4))(2)[Mn(8)O(4)(O(2)CPh)(12)(Et(2)mal)(2)(H(2)O)(2)] with a "Linked-Butterfly" Structure.
Wemple MW; Tsai HL; Wang S; Claude JP; Streib WE; Huffman JC; Hendrickson DN; Christou G
Inorg Chem; 1996 Oct; 35(22):6437-6449. PubMed ID: 11666791
[TBL] [Abstract][Full Text] [Related]
53. In vitro activity of halofantrine and its relationship to other standard antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Le Bras J
Am J Trop Med Hyg; 1992 Oct; 47(4):521-7. PubMed ID: 1443351
[TBL] [Abstract][Full Text] [Related]
54. In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat liver microsomes.
Baune B; Furlan V; Taburet AM; Farinotti R
Xenobiotica; 1999 Jun; 29(6):595-601. PubMed ID: 10426558
[TBL] [Abstract][Full Text] [Related]
55. Halofantrine-phospholipid interactions: monolayer studies.
Go ML; Feng SS
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):871-6. PubMed ID: 11456094
[TBL] [Abstract][Full Text] [Related]
56. Clinical pharmacokinetics of halofantrine.
Karbwang J; Na Bangchang K
Clin Pharmacokinet; 1994 Aug; 27(2):104-19. PubMed ID: 7955774
[TBL] [Abstract][Full Text] [Related]
57. Crystal and molecular structures of trichloro-cobalt(II) complexes of epiquinine, epiquinidine, and epidihydrocinchonine.
Tesarowicz I; Oleksyn BJ; Nitek W
Chirality; 2007 Feb; 19(2):152-61. PubMed ID: 17152047
[TBL] [Abstract][Full Text] [Related]
58. Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution.
Gildenhuys J; Sammy CJ; Müller R; Streltsov VA; le Roex T; Kuter D; de Villiers KA
Dalton Trans; 2015 Oct; 44(38):16767-77. PubMed ID: 26335948
[TBL] [Abstract][Full Text] [Related]
59. Changes in antioxidant status and biochemical indices after acute administration of artemether, artemether-lumefantrine and halofantrine in rats.
Adaramoye OA; Osaimoje DO; Akinsanya AM; Nneji CM; Fafunso MA; Ademowo OG
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):412-8. PubMed ID: 18282195
[TBL] [Abstract][Full Text] [Related]
60. (+)-9-Benzyloxy-α-dihydrotetrabenazine as an important intermediate for the VMAT2 imaging agents: absolute configuration and chiral recognition.
Liu C; Chen Z; Li X; Tang J; Qin X
Chirality; 2013 Apr; 25(4):215-23. PubMed ID: 23532997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
